Crossmark

Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortality

Crossref DOI link: https://doi.org/10.1016/j.gastrohep.2021.02.007

Published Print: 2022-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Terres, Alana Zulian http://orcid.org/0000-0003-4075-757X
Balbinot, Rafael Sartori http://orcid.org/0000-0002-1464-3213
Muscope, Ana Laura Facco http://orcid.org/0000-0003-1572-5576
Longen, Morgana Luisa http://orcid.org/0000-0001-9065-5390
Schena, Bruna http://orcid.org/0000-0001-6501-1032
Cini, Bruna Teston http://orcid.org/0000-0003-0160-2110
Luis Rost, Gilberto Jr. http://orcid.org/0000-0002-5410-0803
Balensiefer, Juline Isabel Leichtweis http://orcid.org/0000-0001-8998-5632
Eberhardt, Louise Zanotto http://orcid.org/0000-0001-9662-7243
Balbinot, Raul Angelo http://orcid.org/0000-0003-4705-0702
Balbinot, Silvana Sartori http://orcid.org/0000-0002-5026-1028
Soldera, Jonathan http://orcid.org/0000-0001-6055-4783
License Information

Text and Data Mining valid from 2022-01-01

stm-asf valid from 2022-01-01

stm-asf valid from 2022-01-01

stm-asf valid from 2022-01-01

stm-asf valid from 2022-01-01

stm-asf valid from 2022-01-01
More Information

This article is maintained by: Elsevier

Article Title: Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortality

Journal Title: Gastroenterología y Hepatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2021.02.007

Content Type: article

Copyright: © 2021 Elsevier España, S.L.U. All rights reserved.